Mechanisms of vascular calcification in CKD-evidence for premature ageing?

Area of Science:

• Cardiovascular Medicine
• Nephrology
• Gerontology

Background:

• Vascular ageing, characterized by vascular smooth muscle cell (VSMC) calcification, is a major cardiovascular disease risk factor.
• Patients with chronic kidney disease (CKD) exhibit accelerated vascular calcification and arterial stiffening, resembling a premature ageing phenotype.
• Uraemic toxins and dysregulated mineral metabolism in CKD drive VSMC damage and promote vascular calcification.

Purpose of the Study:

• To explore the link between uraemic toxins, DNA damage, and vascular ageing in CKD.
• To investigate how ageing mechanisms in CKD may relate to progeric syndromes.
• To identify potential novel therapeutic targets for vascular decline in CKD.

Main Methods:

• Review of existing epidemiological and experimental data on vascular ageing in CKD.
• Analysis of the role of uraemic toxins in VSMC damage and DNA damage.
• Comparison of ageing mechanisms in CKD with genetically induced progeric syndromes.

Main Results:

• Uraemic toxins contribute to VSMC damage and vascular calcification in CKD patients.
• Evidence suggests uraemic toxins promote DNA damage, a key driver of cellular ageing.
• Ageing mechanisms in CKD share similarities with those in progeric syndromes linked to nuclear lamina disruption.

Conclusions:

• CKD accelerates vascular ageing through mechanisms involving uraemic toxins and DNA damage.
• Understanding these ageing pathways opens avenues for novel therapies targeting vascular decline in CKD.
• Therapies targeting tissue-specific ageing mechanisms could treat vascular complications in CKD.